Germany · Series A startup

Who invested in Thryve

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Big Data & AnalyticsBiotechDeveloper ToolsHealthcare

Funding summaryUpdated 26 Oct 2026

$4.4Mraised across 1 round since 2024, from 1 source

Latest round
Series A, $4.4MSept 2024
Led by
Capricorn Partners
Investors
4 (1 led)
See who backed them

The rounds

  1. Sept 2024

Everyone who backed them

Capricorn PartnersVC firm1round, led 1
IBB VenturesGovernment1round
CRB Health TechVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Thryve as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

CRB Health Tech SGEICVC firmPer its own site
Capital CodeAdvisorPer its own site

Quick answers about Thryve

Who invested in Thryve?

Thryve's investors include Capricorn Partners, IBB Ventures, CARMA FUND Management GmbH and CRB Health Tech. Capricorn Partners led its latest round.

How much has Thryve raised?

Thryve has raised $4.4M across 1 round since 2024.

When did Thryve last raise?

Thryve's most recent round was a Series A of $4.4M in Sept 2024, led by Capricorn Partners.

What was Thryve's biggest round?

Its most recent round, $4.4M in Sept 2024, is also its largest on record.

Who backed Thryve first?

Thryve's first round on record, in Sept 2024, was backed by Capricorn Partners, IBB Ventures and CARMA FUND Management GmbH and 1 others.

What stage is Thryve at?

Thryve's latest named round is a Series A, in Sept 2024.

Where is Thryve based?

Thryve is based in Germany.

Who led Thryve's rounds?

Capricorn Partners led the Series A in 2024.

Companies like Thryve

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.